Edwards Lifesciences Corp

EW Com Stk USD1
Create an alert
Sell$84.82
Buy$84.90
$0.31 (0.37%)
Last updated today at 14:41 UTC
Trade
Back to dashboard

Company Information

About this company

Edwards Lifesciences Corporation is a global structural heart company. Its work includes both surgical and transcatheter therapies. Its portfolio of repair and replacement technologies for aortic, mitral, tricuspid and pulmonic heart valves provides a set of treatment options to serve the diverse and complex patients in need. Its product categories include Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical. It provides transcatheter heart valve replacement technologies designed for the minimally invasive replacement of aortic heart valves. Its products include SAPIEN 3 Ultra RESILIA transcatheter heart valve, SAPIEN 3 Ultra transcatheter heart valve, SAPIEN 3 transcatheter heart valve and Alterra adaptive prestent. TMTT category includes PASCAL transcatheter repair system, EVOQUE tricuspid valve replacement system and SAPIEN M3 mitral valve replacement system. INSPIRIS RESILIA aortic valve offers RESILIA tissue and VFit technology.

Key people

Nicholas J. Valeriani
Independent Chairman of the Board
David T. Feinberg
Independent Director
Kieran T. Gallahue
Independent Director
Leslie S. Heisz
Independent Director
Bernard J. Zovighian
Chief Executive Officer, Director
Theodora Mistras
Corporate Vice President, Chief Financial Officer
Wayne T. Markowitz
Senior Vice President, Japan, Greater China, and Asia Pacific (JAPAC)
Donald E. Bobo
Corporate Vice President - Strategy and Corporate Development
Annette Maria Bruels
Corporate Vice President - Europe, Middle East, Africa, Canada and Latin America (EMEACLA)
Daveen Chopra
Corporate Vice President - Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart (SURG) and Implantable Heart Failure Management (IHFM)
Daniel J. Lippis
Corporate Vice President - Transcatheter Aortic Valve Replacement
Leslie C. Davis
Independent Director
Click to see more

Key facts

  • Shares in issue
    658.80m
  • EPIC
    EW
  • ISIN
    US28176E1082
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • Market cap
    $48.94bn
  • Employees
    16,000
  • Exchange
    New York Stock Exchange
  • Index
    S&P 500, TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.